Izotropic (OTCMKTS:IZOZF – Get Free Report) issued its earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02), Zacks reports.
Izotropic Price Performance
Shares of IZOZF stock opened at $0.13 on Wednesday. Izotropic has a twelve month low of $0.10 and a twelve month high of $0.37. The company’s 50-day moving average price is $0.17 and its 200-day moving average price is $0.18.
About Izotropic
Izotropic Corporation is a medical technology company focused on developing advanced breast-imaging systems. Its primary product is the IzoView breast computed tomography (CT) system, which is designed to generate three-dimensional images of the breast and support the detection and evaluation of breast disease.
Unlike conventional mammography, the IzoView system is designed to image the breast without the same type of compression used in standard mammographic procedures. The company has also explored contrast-enhanced breast CT applications, with the goal of providing additional information for clinicians assessing suspicious findings and other breast conditions.
Izotropic is based in Richmond, British Columbia, Canada, and is focused on product development, clinical validation, regulatory activities and potential commercialization of its imaging technology.
Recommended Stories
- Five stocks we like better than Izotropic
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
